Dapagliflozin Prescribing at THE WILLOW GROUP
Drugs used in diabetes | Endocrine System
Items (12m)
11,084
Total Quantity
390.1K
NHS Cost
£484.7K
vs National Avg
+785.1%
THE WILLOW GROUP prescribed 11,084 items of Dapagliflozin over the last 12 months at a cost of £484,733 to the NHS. This is 785.1% above the national average prescribing rate. Dapagliflozin is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
809
Jun 2026
742
Jun 2026
865
Jun 2026
827
Jun 2026
950
Jun 2026
959
Jun 2026
908
Jun 2026
985
Jun 2026
1,039
Jun 2026
942
Jun 2026
1,016
Jun 2026
1,042
Prescribing Details
| Total Items | 11,084 |
|---|---|
| Total Quantity | 390,079 |
| Total NHS Cost | £484,733 |
| Presentations | 3 different forms |
| vs National Average | +785.1% |
Dapagliflozin Prescribing Comparison
| This practice | 11,084 items |
|---|---|
| National average per practice | 1,252 items |
| Difference | +785.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.